Search

everythinglearnresearchcommunity

for

Search:↓

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Regulatory γδ T cells help protect hair follicles from alopecia areata and promote hair regrowth.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

AP-2α and AP-2β proteins are essential for healthy adult skin and hair.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

An 8-year-old girl developed a rare skin condition in a linear pattern on one side of her body after a lung infection, which improved with treatment.

Permanent hair dye may cause total hair loss.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Early intervention and patient education are crucial for managing alopecia areata.

The study found new details about human hair growth and suggests that preventing a specific biological pathway could potentially treat hair graying.

Nitric oxide is important for skin functions and both helps protect against and contributes to skin inflammation and sensitization.

MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.

Burn scars form abnormally due to changes in wound healing, and more research is needed to improve treatments.

308-nm excimer light therapy helped over a third of treatment-resistant alopecia universalis patients regrow most of their hair.

A girl with severe hair loss saw hair regrowth after using cannabis.